What Global Regulatory Services does

Global Regulatory Services (GRS) is a privately-held UK regulatory affairs and quality compliance consultancy serving the life sciences industry, founded in 2007 by Bobby Deal and Greer Deal and headquartered in Milton, Cambridgeshire, with a regional office in Lund, Sweden (opened 2017). The firm operates an asset-light model, delivering services through a global network of independent professionals rather than a proprietary technology platform, with claimed coverage across the UK, Europe, North America, and Asia. Its 17+ service lines span regulatory strategy and submissions, pharmacovigilance, orphan drug designation, US FDA support, eCTD publishing, medical devices and IVDs (including MDR/IVDR), biotechnology and biosimilars, generics, herbals and botanicals, nutraceuticals, nanotechnology, translation services, and post-Brexit UK Responsible Person and Regulatory Virtual Importer services. GRS also sells standardized Good Distribution Practice (GDP) training courses (individual online £160–£250, in-house group £2,600 for up to 8 people) and operates a wholly-owned cosmetics subsidiary, Crème de la Crème Limited (launched March 2016).

GRS earns revenue exclusively through professional services engagements plus training course fees, with consulting priced on a quote basis. Go-to-market is sales-led via direct business development, industry conferences (BIO, TOPRA, Medicon Village events), partnerships (HealthTech Enterprise, MedCity, YourEncore), an active content-marketing engine (blog, case studies, email newsletter), and ongoing industry association memberships. The client base spans startups to multinationals, with named enterprise clients including GlaxoSmithKline (continuous manufacturing regulatory work), Abcam (regulatory advice underpinning the Ascent Scientific acquisition and AbcamBiochemicals launch), Babylon Partners, and Cambridge University Hospitals NHS Foundation Trust. EU SME Status (awarded 25 April 2014) and $2M of professional liability insurance with worldwide coverage serve as trust signals reinforcing eligibility for both SME-fee incentives and large-client mandates.

Name

Global Regulatory Services

Legal name

Global Regulatory Services Limited

Website

https://globalregulatoryservices.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

11–50 employees

Short description

Global Regulatory Services is a UK-based consultancy providing regulatory affairs and quality compliance services to life sciences companies worldwide, from startups to multinationals, via a global network of independent specialists.

Ownership category

akta.pro rank

Product category

Life Sciences Regulatory Affairs Consulting

SIC

Services-Management Services (8741)

akta.pro primary industry

Regulatory Operations & Publishing (eCTD, RIM, Submission Management) (HLAGAKAC)

akta.pro secondary industries

Product, Safety & Quality Compliance (incl. Regulatory Affairs) (BPAHAFAM), Drug Regulators (Human Pharmaceuticals) (HLAJADAA)

Keywords

• Regulatory affairs consulting
• Quality compliance services
• Pharmacovigilance consulting
• Medical device regulatory
• Pharmaceutical regulatory support

Headquarters

HQ city

Ely

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations, Infrastructure, Technology or R&D

Revenue model

1. Regulatory Affairs Consulting: GRS provides comprehensive regulatory affairs and quality compliance consulting services to life sciences companies, including regulatory strategy, product submissions, and compliance support across pharmaceuticals, medical devices, nutraceuticals, and other sectors.
2. Training Courses: GRS offers GDP (Good Distribution Practice) training courses in various formats including online and in-house group training, with certification valid for 2 years.
3. Pharmacovigilance Services: Via strategic partner, GRS provides complete pharmacovigilance packages including trained personnel, QP services, auditing, and regulatory support.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

Global Regulatory Services is a professional consultancy providing regulatory affairs and quality compliance advisory services to life sciences companies. It supports clients across pharmaceuticals, biotechnology, medical devices, IVDs, generics, biosimilars, orphan drugs, nutraceuticals, herbals, cosmetics, and nanotechnology through regulatory strategy, product submissions, pharmacovigilance, training, and acting as UK Responsible Person and Regulatory Virtual Importer.

Product overview

Global Regulatory Services (GRS) operates as a global consultancy offering regulatory affairs and quality compliance services to the life science industry. The company provides a portfolio of advisory services rather than a unified software product. Core service offerings include regulatory strategy and guidance, pharmacovigilance, orphan drug designation support, US FDA regulatory assistance, translation services, and specialized services for nanotechnology, medical devices/IVDs, generics, herbals/botanicals, biotechnology/biosimilars, and cosmetics. GRS also delivers Good Distribution Practice training courses and acts as UK Responsible Person and Regulatory Virtual Importer. Services are delivered through the company's global network of independent professionals and specialists. The company also operates a sister company, Crème de la Crème Limited, focused specifically on cosmetics regulatory compliance.

Differentiator

Problem solved

Functional benefit

Brands

• Crème de la Crème Limited: Subsidiary company dedicated to providing regulatory advice and support to the Cosmetic Industry with focus on European Regulation 1223/2009.

Products and services

• Regulatory Strategy, Guidance & Support Consultancy service providing strategic regulatory advice, evaluation of regulatory procedures, and overall regulatory development project support for the life science industry.
• Pharmacovigilance Services Complete pharmacovigilance package including trained PV personnel, Qualified Person services, PSUR writing, clinical expert reports, risk management plans, auditing, ADR literature searches, and expedited reporting.
• Orphan Drugs Services Consultancy for obtaining orphan drug designation status, including EMA and FDA application support, protocol assistance, and incentive navigation.
• Nutraceuticals & Functional Foods Services Regulatory advice on nutraceuticals, functional foods, vitamins, supplements, and novel foods legislation across EU, UK (MHRA/FSA), and US (FDA).
• US FDA Regulatory Support Full range of regulatory and clinical services for entering the US market, including cGMP consulting, clinical monitoring, FDA submissions (ANDA, NDA, BLA, 510(k)), and strategic planning.
• Medical Devices & In-Vitro Diagnostics Services Support for medical device and IVD regulatory pathways in America, Europe, and Rest-of-World, including MDR/IVDR compliance, CE marking, and technical documentation.
• Electronic Common Technical Document (eCTD) Services eCTD publishing services using state-of-the-art software for electronic submissions including CTAs and full Marketing Authorisations, in both eCTD and non-eCTD electronic submission formats.
• Generics Regulatory Services Regulatory support for generic drug submissions including Marketing Authorisation Applications, change of ownership, variations, labelling updates, and notarised documentation.
• Herbals & Botanicals (Global) Services Regulatory compliance support for herbal and botanical products worldwide, including classification advice and navigation of diverse regulatory frameworks.
• Herbals & Botanicals (Europe) Services Support for EU herbal product compliance under the Traditional Herbal Medicines Registration Scheme (THMRS), including product assessments and Traditional Herbal Registration applications.
• Biotechnology, Biological & Biosimilar Products Services Regulatory strategy support for biotechnology, biological products, and biosimilars including product definition, clinical trial design, scientific advice preparation, and marketing authorisation submissions.
• Cosmetics (Europe) Services Regulatory compliance support for the European cosmetics industry under EU Regulation 1223/2009, provided through sister company Crème de la Crème Limited.
• NanoTechnology Regulatory Services Regulatory guidance for nanotechnology and nanomedicine development, including evidence-based assessments, business intelligence translation, and submission support.
• Good Distribution Practice (GDP) Training Courses GDP training courses for pharmaceutical supply chain professionals including Operations Training (1 day), Advanced Refresher, Driver GDP, and Driver Refresher courses available in-person and online, with certification valid for 2 years (Individual Online UK £250; In-House Group UK £2,600 for up to 8 people; Advanced Refresher £160 UK / €180 EU; Driver GDP £230 UK / €250 EU).
• UK Responsible Person (UKRP) Services Comprehensive UKRP services for medical devices, pharmaceuticals, cosmetics, ATMPs, nutraceuticals, veterinary products, digital health, and cannabis-based medicinal products, including MHRA registration and compliance management.
• Regulatory Virtual Importer (RVI) Services UK MHRA regulatory importer services for medical devices and IVDs, including UKCA/CE mark verification, documentation review, economic operator registration, complaint management, and CAPA support.
• Translation Services Multi-language document translation for life sciences using experienced translators, with second-translator verification, copy-editing, and back-translation services.

Quantifiable outcome

• SME clients can access 90-100% fee reductions on EMA scientific advice and inspections
• +2 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Nine partnerships are on record, tiered core and minor.

• HealthTech EnterprisecoreStrategic or Co-development Partner · 7 August 2025Strategic collaboration announced in 2025 to expand support for HealthTech innovators, creating a powerful platform for end-to-end support across the entire health tech lifecycle.
• Cannabis Industry CouncilminorOthers · 8 July 2025GRS officially joined the Cannabis Industry Council (CIC) in July 2025 to support the global medicinal cannabis movement.
• UKRPA (UK Responsible Person Association)minorOthers · 29 October 2024GRS joined UKRPA in October 2024 to expand services and ensure regulatory success, particularly for UK medical device market post-Brexit.
• MedCityminorStrategic or Co-development Partner · 24 May 2024GRS partnered with MedCity for industry collaboration and knowledge sharing in the life sciences sector.
• Ambitious Essex Innovation AcceleratorcoreStrategic or Co-development Partner · 1 May 2024Partnership to foster innovation and regulatory compliance as part of a pioneering initiative supporting innovative companies in Essex.
• Health & Life Sciences PledgeminorOthers · 16 January 2024GRS joined as a pledgee in the Health & Life Sciences Pledge (HLS Pledge), an initiative dedicated to fostering innovation and tackling regional health challenges in the North East and North Cumbria (NENC).
• Medicon VillageminorOthers · 5 September 2017GRS established an office at Medicon Village in Lund, Sweden. Medicon Village is a life science research park. GRS has been active in the Nordic region since 2017.
• YourEncorecoreStrategic or Co-development Partner · 30 June 2016Formal alliance between GRS and YourEncore to deliver on-demand experts in life sciences and consumer health industries. The partnership was described as 'Bridge over the Pond', enabling GRS to serve North American clients and YourEncore to access European regulatory expertise.
• Crème de la Crème LimitedcoreOthers · 7 March 2016Subsidiary company launched in March 2016 dedicated to providing regulatory services to the cosmetic industry, focusing on requirements of European Regulation 1223/2009.

Scale indicators3 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• Parexel International: Large global CRO with substantial regulatory affairs and pharmacovigilance practices serving pharma/biotech. Competes with GRS for mid-to-large regulatory programmes but as part of a much broader clinical/commercial portfolio.
• IQVIA: Largest global CRO and life sciences data/technology company with a dedicated regulatory affairs practice. Overlaps with GRS in regulatory strategy and submissions, but at vastly greater scale and with proprietary technology (RIMS).
• ICON plc: Global CRO providing clinical, regulatory and consulting services to pharma/biotech. Directly comparable to GRS in regulatory affairs consulting, though typically delivered as part of large multi-service engagements.
• Evidera (PPD/Thermo Fisher): Health economics, outcomes research and regulatory consulting business within PPD/Thermo Fisher. Comparable to GRS in regulatory and scientific advisory for pharma/biotech, but owned by a large strategic parent.
• Syneos Health: Global biopharmaceutical solutions organization with regulatory affairs and pharmacovigilance capabilities. Overlaps with GRS in regulatory strategy but typically serves larger enterprise clients.
• Charles River Laboratories: Large CRO with established regulatory and safety assessment practices for pharma/biotech. Comparable in regulatory advisory scope but at substantially greater scale and with broader non-clinical/clinical portfolio.

Direct peers

• PharmaLex: Mid-sized life sciences regulatory affairs and compliance consultancy with global footprint. Direct overlap with GRS in regulatory strategy, submissions, pharmacovigilance and quality compliance for pharma/biotech.
• ProPharma Group: Mid-sized regulatory, compliance and pharmacovigilance consultancy for life sciences. Closely comparable in size, service mix and niche positioning to GRS, especially across pharma, biotech and medical devices.

Emerging players

• Boyd Regulatory Services: Smaller specialist regulatory affairs consultancy focused on medical devices and IVDs. Direct overlap with GRS in the medical device and IVDR/MDR service line but with narrower vertical focus.
• JFDI Regulatory: UK-based boutique regulatory affairs consultancy serving pharma, biotech and medical devices. Highly comparable in size, geography and service mix to GRS — closest head-to-head peer for SME/startup clients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Global_Reg_Svcs
• LinkedInlinkedin.com/company/global-regulatory-services

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Global Regulatory Services